Home Mass Spectrometry-Based Proteomics: Current Status and Potential Use in Clinical Chemistry
Article
Licensed
Unlicensed Requires Authentication

Mass Spectrometry-Based Proteomics: Current Status and Potential Use in Clinical Chemistry

  • Pierre-Alain Binz , Denis F. Hochstrasser and Ron D. Appel
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 41 Issue 12

Abstract

For some years now, scientists have been spending a lot of effort in developing methods to analyse and compare complex protein samples. One of the goals of such global analyses of what is known as proteomes is to discover specific protein markers–or fingerprints of protein markers−from various types of affected biological samples. Considering the battery of technologies currently available, mass spectrometry (MS) constitutes an essential tool in proteomics. We describe here the type of MS instrumentation that is currently dedicated to proteomics research. We also describe the major experimental workflows that are typically used in proteomics today, with a focus on those incorporating MS as a major analysis tool.

:
Published Online: 2005-06-01
Published in Print: 2003-12-04

Copyright © 2003 by Walter de Gruyter GmbH & Co. KG

Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2003.237/pdf
Scroll to top button